This week marked a major milestone in medicine: On Wednesday, a Food and Drug Administration panel unanimously recommended the approval of the first CAR-T therapy, a pioneering new cancer drug from Novartis that genetically engineers a patient’s own white blood cells to recognize and attack the cancer cells invading…
Source: Gizmodo – Did the FDA Really Just Approve the First Gene Therapy Treatment?